Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2009

Open Access 01-12-2009 | Research

Variables that influence HIV-1 cerebrospinal fluid viral load in cryptococcal meningitis: a linear regression analysis

Authors: Diego M Cecchini, Ana M Cañizal, Haroldo Rojas, Alicia Arechavala, Ricardo Negroni, María B Bouzas, Jorge A Benetucci

Published in: Journal of the International AIDS Society | Issue 1/2009

Login to get access

Abstract

Background

The central nervous system is considered a sanctuary site for HIV-1 replication. Variables associated with HIV cerebrospinal fluid (CSF) viral load in the context of opportunistic CNS infections are poorly understood. Our objective was to evaluate the relation between: (1) CSF HIV-1 viral load and CSF cytological and biochemical characteristics (leukocyte count, protein concentration, cryptococcal antigen titer); (2) CSF HIV-1 viral load and HIV-1 plasma viral load; and (3) CSF leukocyte count and the peripheral blood CD4+ T lymphocyte count.

Methods

Our approach was to use a prospective collection and analysis of pre-treatment, paired CSF and plasma samples from antiretroviral-naive HIV-positive patients with cryptococcal meningitis and assisted at the Francisco J Muñiz Hospital, Buenos Aires, Argentina (period: 2004 to 2006). We measured HIV CSF and plasma levels by polymerase chain reaction using the Cobas Amplicor HIV-1 Monitor Test version 1.5 (Roche). Data were processed with Statistix 7.0 software (linear regression analysis).

Results

Samples from 34 patients were analyzed. CSF leukocyte count showed statistically significant correlation with CSF HIV-1 viral load (r = 0.4, 95% CI = 0.13-0.63, p = 0.01). No correlation was found with the plasma viral load, CSF protein concentration and cryptococcal antigen titer. A positive correlation was found between peripheral blood CD4+ T lymphocyte count and the CSF leukocyte count (r = 0.44, 95% CI = 0.125-0.674, p = 0.0123).

Conclusion

Our study suggests that CSF leukocyte count influences CSF HIV-1 viral load in patients with meningitis caused by Cryptococcus neoformans.
Literature
1.
go back to reference Fierer DS, Klotman ME: Kidney and central nervous system as reservoirs of HIV infection. Curr Opin HIV AIDS 2006, 1 (2) : 115–120.PubMed Fierer DS, Klotman ME: Kidney and central nervous system as reservoirs of HIV infection. Curr Opin HIV AIDS 2006, 1 (2) : 115–120.PubMed
2.
go back to reference Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, Giner J, Dean B, Robertson K, Hart CE, Lennox JL, Eron JJ Jr, Hicks CB: HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS 2001, 15: 837–45.CrossRefPubMed Pilcher CD, Shugars DC, Fiscus SA, Miller WC, Menezes P, Giner J, Dean B, Robertson K, Hart CE, Lennox JL, Eron JJ Jr, Hicks CB: HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS 2001, 15: 837–45.CrossRefPubMed
3.
go back to reference Bell JE: An update on the neuropathology of HIV in the HAART era. Histopathology 2004, 45: 549–59.CrossRefPubMed Bell JE: An update on the neuropathology of HIV in the HAART era. Histopathology 2004, 45: 549–59.CrossRefPubMed
4.
go back to reference Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG, Paxinos EE, Price RW: Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infectious Diseases 2005, 5: 98.CrossRefPubMed Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG, Paxinos EE, Price RW: Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infectious Diseases 2005, 5: 98.CrossRefPubMed
5.
go back to reference Gisslén M, Chiodi F, Fuchs D, Norkrans G, Svennerholm B, Wachter H, Wachter H, Hagberg L: Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis 1994, 26: 523–33.CrossRefPubMed Gisslén M, Chiodi F, Fuchs D, Norkrans G, Svennerholm B, Wachter H, Wachter H, Hagberg L: Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study. Scand J Infect Dis 1994, 26: 523–33.CrossRefPubMed
6.
go back to reference Price RW, Staprans S: Measuring the "viral load" in cerebrospinal fluid human immunodeficiency virus infection: window into brain infection? Ann Neurol 1997, 42: 675–78.CrossRefPubMed Price RW, Staprans S: Measuring the "viral load" in cerebrospinal fluid human immunodeficiency virus infection: window into brain infection? Ann Neurol 1997, 42: 675–78.CrossRefPubMed
7.
go back to reference Conrad AJ, Schmid P, Syndulko K, Singer EJ, Nagra RM, Russell JJ, Tourtellotte WW: Quantifying HIV-1 RNA using polimerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10 (4) : 425–435.CrossRefPubMed Conrad AJ, Schmid P, Syndulko K, Singer EJ, Nagra RM, Russell JJ, Tourtellotte WW: Quantifying HIV-1 RNA using polimerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 10 (4) : 425–435.CrossRefPubMed
8.
go back to reference Christo PP, Greco DB, Aleixo AW, Livramento JA: HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital. Arq Neuropsiquiatr 2005, 63: 907–13.PubMed Christo PP, Greco DB, Aleixo AW, Livramento JA: HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital. Arq Neuropsiquiatr 2005, 63: 907–13.PubMed
9.
go back to reference Gisslén M, Fuchs D, Svennerholm B, Hagberg L: Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr 1999, 21 (4) : 271–276.PubMed Gisslén M, Fuchs D, Svennerholm B, Hagberg L: Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection. J Acquir Immune Defic Syndr 1999, 21 (4) : 271–276.PubMed
10.
go back to reference Hagberg L, Forsman A, Norkrans G, Rybo E, Svennerholm L: Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients. Infection 1988, 16: 13–18.CrossRefPubMed Hagberg L, Forsman A, Norkrans G, Rybo E, Svennerholm L: Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients. Infection 1988, 16: 13–18.CrossRefPubMed
11.
go back to reference Yilmaz A, Fuchs D, Hagberg L, Nillroth U, Ståhle L, Svensson JO, Gisslén M: Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study. BMC Infectious Diseases 2006, 6: 63.CrossRefPubMed Yilmaz A, Fuchs D, Hagberg L, Nillroth U, Ståhle L, Svensson JO, Gisslén M: Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study. BMC Infectious Diseases 2006, 6: 63.CrossRefPubMed
12.
go back to reference Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, Abramson I, Grant I, McCutchan JA: Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 2000, 54: 927–36.PubMed Ellis RJ, Gamst AC, Capparelli E, Spector SA, Hsia K, Wolfson T, Abramson I, Grant I, McCutchan JA: Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 2000, 54: 927–36.PubMed
13.
go back to reference Morris L, Silber E, Sonnenberg P, Eintracht S, Nyoka S, Lyons SF, Saffer D, Koornhof H, Martin DJ: High Human Immunodeficiency Virus Type 1 RNA Load in the Cerebrospinal Fluid from Patients with Lymphocytic Meningitis. J Infect Dis 1998, 177: 473–76.CrossRefPubMed Morris L, Silber E, Sonnenberg P, Eintracht S, Nyoka S, Lyons SF, Saffer D, Koornhof H, Martin DJ: High Human Immunodeficiency Virus Type 1 RNA Load in the Cerebrospinal Fluid from Patients with Lymphocytic Meningitis. J Infect Dis 1998, 177: 473–76.CrossRefPubMed
14.
go back to reference Martin C, Albert J, Hansson P, Pehrsson P, Link H, Sönnerborg A: Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 17 (3) : 214–219.PubMed Martin C, Albert J, Hansson P, Pehrsson P, Link H, Sönnerborg A: Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 17 (3) : 214–219.PubMed
15.
go back to reference Brew BJ, Pemberton L, Cunningham P, Law MG: Levels of Human Immunodeficiency Virus type 1 RNA in Cerebrospinal Fluid Correlate with AIDS Dementia Stage. J Infect Dis 1997, 175: 963–66.CrossRefPubMed Brew BJ, Pemberton L, Cunningham P, Law MG: Levels of Human Immunodeficiency Virus type 1 RNA in Cerebrospinal Fluid Correlate with AIDS Dementia Stage. J Infect Dis 1997, 175: 963–66.CrossRefPubMed
16.
go back to reference Buchanan KL, Murphy JW: What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 1998, 4: 71–83.CrossRefPubMed Buchanan KL, Murphy JW: What makes Cryptococcus neoformans a pathogen? Emerg Infect Dis 1998, 4: 71–83.CrossRefPubMed
17.
go back to reference Huffnagle GB, McNeil LK: Dissemination of C. neoformans to the central nervous system: role of chemokines, Th1 immunity and leukocyte recruitment. J Neurovirol 1999, 5: 76–81.CrossRefPubMed Huffnagle GB, McNeil LK: Dissemination of C. neoformans to the central nervous system: role of chemokines, Th1 immunity and leukocyte recruitment. J Neurovirol 1999, 5: 76–81.CrossRefPubMed
18.
go back to reference Chaka W, Heyderman R, Gangaidzo I, Robertson V, Mason P, Verhoef J, Verheul A, Hoepelman AI: Cytokine Profiles in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients with Cryptococcal Meningitis: No Leukocytosis despite High Interleukin-8 Levels. J Infect Dis 1997, 176: 1633–36.CrossRefPubMed Chaka W, Heyderman R, Gangaidzo I, Robertson V, Mason P, Verhoef J, Verheul A, Hoepelman AI: Cytokine Profiles in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients with Cryptococcal Meningitis: No Leukocytosis despite High Interleukin-8 Levels. J Infect Dis 1997, 176: 1633–36.CrossRefPubMed
19.
go back to reference Garlipp CR, Rossi CL, Botín PV: Cerebrospinal fluid in Acquired Immunodeficiency Syndrome with and without neurocryptococcosis. Rev Inst Med Trop Sao Paulo 1997, 39 (6) : 323–325.PubMed Garlipp CR, Rossi CL, Botín PV: Cerebrospinal fluid in Acquired Immunodeficiency Syndrome with and without neurocryptococcosis. Rev Inst Med Trop Sao Paulo 1997, 39 (6) : 323–325.PubMed
20.
go back to reference Pettoello-Mantovani M, Casadevall A, Kollman TR, Rubinstein A, Goldstein H: Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans . Lancet 1992, 339: 21–23.CrossRefPubMed Pettoello-Mantovani M, Casadevall A, Kollman TR, Rubinstein A, Goldstein H: Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans . Lancet 1992, 339: 21–23.CrossRefPubMed
21.
go back to reference Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA: Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997, 42: 679–88.CrossRefPubMed Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA: Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997, 42: 679–88.CrossRefPubMed
22.
go back to reference Brouwer AE, Teparrukkul P, Pinpraphaporn S, Larsen RA, Chierakul W, Peacock S, Day N, White NJ, Harrison TS: Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis. J Infect Dis 2005, 192: 681–84.CrossRefPubMed Brouwer AE, Teparrukkul P, Pinpraphaporn S, Larsen RA, Chierakul W, Peacock S, Day N, White NJ, Harrison TS: Baseline correlation and comparative kinetics of cerebrospinal fluid colony-forming unit counts and antigen titers in cryptococcal meningitis. J Infect Dis 2005, 192: 681–84.CrossRefPubMed
23.
go back to reference Siddiqui AA, Brouwer AE, Wuthiekanun V, Jaffar S, Shattock R, Irving D, Sheldon J, Chierakul W, Peacock S, Day N, White NJ, Harrison TS: IFN gamma at the site of infection determines the rate of clearance of infection in cryptococcal meningitis. J Immunol 2005, 174: 1746–50.PubMed Siddiqui AA, Brouwer AE, Wuthiekanun V, Jaffar S, Shattock R, Irving D, Sheldon J, Chierakul W, Peacock S, Day N, White NJ, Harrison TS: IFN gamma at the site of infection determines the rate of clearance of infection in cryptococcal meningitis. J Immunol 2005, 174: 1746–50.PubMed
Metadata
Title
Variables that influence HIV-1 cerebrospinal fluid viral load in cryptococcal meningitis: a linear regression analysis
Authors
Diego M Cecchini
Ana M Cañizal
Haroldo Rojas
Alicia Arechavala
Ricardo Negroni
María B Bouzas
Jorge A Benetucci
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of the International AIDS Society / Issue 1/2009
Electronic ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-12-33

Other articles of this Issue 1/2009

Journal of the International AIDS Society 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.